Cite
HARVARD Citation
Pathak, P. et al. (2019). Quinazoline based 1, 3, 5‐triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study. Archiv der Pharmazie. 352 (9), p. n/a. [Online].